Prophylaxis of Ileostomy Closure Site Hernia by Placing Mesh
- Conditions
- Loop Ileostomy Closure
- Interventions
- Procedure: MESHProcedure: NO MESHRadiation: Post-operative ImagingRadiation: Pre-operative ImagingOther: Blood Test and C-reactive protein at 4th day
- Registration Number
- NCT02226887
- Brief Summary
Design Prospective , randomized, parallel phase IV.
Objectives Main objective
* Evaluate the effectiveness of the placement of a resorbable mesh in the prevention of incisional hernia of the abdominal wall at the site of a loop ileostomy when it is "closed " to rebuild the intestinal transit. The effectiveness evaluation is done by tracking with scheduled patient visits for 12 months, assessing the physical examination the presence or absence of an incisional hernia and an abdominal tomography at the end of the 12 months .
Secondary objectives Comparison of complications(morbidity and mortality) to assess safety and tolerability of the placement of the mesh described .
- Detailed Description
Experimental: Reinforcement with Absorbable Mesh Closure of the ileostomy closure incision is reinforced with insertion of a rectangular segment (1 cm wide and the length corresponding to the incision) of a prosthetic commercially available GORE® BIO-A® Tissue Reinforcement prosthesis (W. L. Gore \& Associates, Flagstaff, Arizona, USA) mesh. The BIO-A® prosthesis is inserted using a "sandwich" method between the edges of the incision and maintained in situ with a continuous polydioxanone (PDS) suture following a suture length to wound length (SL:WL) ratio of 4:1.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 120
- Patients undergoing a loop ileostomy closure
- Patients under 18
- Pregnancy and Lactation
- Patients allergic to polyglycolic / trimethylene carbonate
- Carrier of prosthetic mesh in the ostomy
- Patients presenting midline hernia.
- Patients affected by inflammatory bowel disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description NO MESH Post-operative Imaging - NO MESH Pre-operative Imaging - MESH Pre-operative Imaging - MESH MESH - MESH Post-operative Imaging - MESH Blood Test and C-reactive protein at 4th day - NO MESH Blood Test and C-reactive protein at 4th day - NO MESH NO MESH -
- Primary Outcome Measures
Name Time Method Eventration 1 year Measured by clinical checks at 1 - 6 - 12 months and Abdominal tomography 1 year after the surgery.
- Secondary Outcome Measures
Name Time Method Iatrogenic problems 30 days after surgery Damage to structures such as ureters, bowel loops artery / iliac vein ....
* This is a Surgical and Clinical measure supported by image if necessary.
* All the morbidity problems are reported independently.Cardiac complications 30 days after surgery acute myocardial infarction, angor pectoris , atrial fibrillation, acute pulmonary edema
* This is a Clinical measure supported by more specific tests if necessary.
* All the morbidity problems are reported independently.
* Cardiologist report will be required for including this itemsGastrointestinal complications 30 days after surgery Liver failure, gastrointestinal bleeding, severe malnutrition, ...
* This is a Clinical measure supported by blood test and further test if necessary
* All the morbidity problems are reported independently.Local complications 30 days after surgery Hematoma, seroma, evisceration
* This is a Clinical measure
* All the morbidity problems are reported independentlyOcclusive problems 30 days after surgery Intestinal occlusion, Anastomotic stenosis, Prolonged ileus(\>5days),....
* This is a Clinical measure supported by image if necessary
* All the morbidity problems are reported independently.
* 1 patient can suffer a prolonged ileus and Anastomotic stenosis and both will be reported.Bleeding problems 30 days after surgery Hemoperitoneum, abdominal hematoma,anastomotic bleeding ....
* This is a Clinical measure supported by image if necessary.
* All the morbidity problems are reported independently.
* The amount of blood loss won't be specifiedNephro-urinary complications 30 days after surgery Acute urinary retention, Acute renal failure, cystitis, pyelonephritis ...
* This is a Clinical measure supported by more specific tests if necessary.
* All the morbidity problems are reported independently.Impaired healing 30 days after surgery Anastomotic leak rate , intestinal fistula , vesical fistula, peritonitis...
* This is a Clinical measure always supported by image tests.
* All the morbidity problems are reported independently.Neurological complications 30 days after surgery Disorientation, cerebral vascular accident, ...
* This is a Clinical measure.
* All the morbidity problems are reported independently.
* Neurologist report will be required beyond disorientation.Respiratory complications 30 days after surgery Pneumonia, Atelectasis, Pulmonary embolism, Respiratory distress syndrome ...
* This is a Clinical measure always supported by image .
* All the morbidity problems are reported independently.Vascular Complications 30 days after surgery Deep venous thrombosis, phlebitis, thrombophlebitis, ...
* This is a Clinical measure supported by more specific test if necessary .
* All the morbidity problems are reported independentlyLocal infection 30 days after surgery Superficial, deep, body-cavity
* This is a Clinical measure supported by image if necessary
* All the morbidity problems are reported independentlyHospital stay Days Hospital stay since surgery is done
Trial Locations
- Locations (1)
Hospital General Universitario Vall d´Hebron
🇪🇸Barcelona, Spain